Marchex INC

Marchex announced its second quarter 2026 financial results, reporting improved Adjusted EBITDA and early positive momentum following the Archenia acquisition, though revenue saw a slight decrease.

Marchex reported Q1 2026 results with a narrowed net loss and improved Adjusted EBITDA, driven by AI integration and progress on the Archenia acquisition.

Marchex, Inc. has entered into a sublease agreement for its Seattle office space, resulting in a non-cash impairment charge of approximately $203,000.

Marchex, Inc. has entered into a settlement agreement to resolve a civil action, agreeing to pay $1.75 million over three installments.

Marchex reports Q4 2025 revenue decline and increased net loss, while outlining positive 2026 outlook and Archenia acquisition progress.

Marchex, Inc.'s Compensation Committee approved annual cash bonuses for its executive officers for fiscal year 2025.

Marchex, Inc. reported a decrease in revenue for the first quarter of 2026 compared to the prior year, alongside progress on a strategic acquisition.

Marchex, Inc. reported a revenue decline in Q3 2025 and for the nine months ended September 30, 2025, while announcing an Agreement in Principle to acquire Archenia, Inc. for $10 million in convertible notes and potential earnout shares.

Marchex, Inc. reported a net income of $85,000 for Q2 2025, a significant improvement from a prior year loss, despite a 3% revenue decrease.

Marchex's Q1 2025 revenue decreased slightly to $11.4 million, impacted by lower call volumes and customer consolidation, while the company underwent reorganization efforts.

Marchex's Q3 2024 results show a slight revenue decrease but a significant improvement in net loss compared to the same period last year.

Marchex's Q2 2024 results show a revenue decrease of 3% year-over-year, alongside reduced operating expenses as the company continues its strategic realignment.

Marchex, Inc. filed an amendment to its 2025 Annual Report to provide required Part III information regarding directors, executive compensation, and corporate governance.

Marchex reports a 6% revenue decline in 2025 to $45.4 million, alongside increased net losses, while actively investing in AI-powered conversational intelligence and pursuing strategic acquisitions.

Marchex files an amendment to its 2024 Annual Report on Form 10-K to include Part III information regarding directors, executive officers, and corporate governance, which was initially omitted.

Marchex's 10-K filing reveals a decrease in net loss driven by cost efficiencies and AI integration, despite a slight revenue dip in fiscal year 2024.

Marchex has filed an amendment to its annual report on Form 10-K to include previously omitted Part III information and correct an error in the reported market value of non-affiliate equity.

Marchex's 2023 annual report highlights a focus on AI-driven conversational intelligence despite a revenue decrease, with strategic shifts towards a unified technology platform and new product launches.

Marchex Inc. reports that Russell C. Horowitz acquired $4,864,865 in convertible debt as part of the acquisition of Archenia, Inc.

Marchex Inc. announces the acquisition of Archenia, Inc. and issuance of convertible debt to reporting person Michael A. Arends.

Marchex Inc.'s President and Chief Revenue Officer, Troy Hartless, acquired 87,500 shares of Class B Common Stock through the vesting of restricted stock units.

Marchex Inc.'s Chief Financial Officer, Brian Nagle, acquired 7,500 shares of Class B Common Stock through the vesting of restricted stock units.

Marchex Inc.'s Chief Operating Officer, Francis J Feeney, acquired 62,500 shares of Class B Common Stock through the vesting of restricted stock units.

Marchex Inc. Director Manuel W. Wisehart was granted 50,000 employee stock options with an exercise price of $1.64, vesting over two years.

Marchex, Inc. has filed its definitive proxy statement (DEFA14A) with the SEC, signaling an upcoming shareholder meeting.

Marchex, Inc. announces its 2025 Annual Meeting of Stockholders to elect directors and ratify its independent accounting firm, emphasizing electronic proxy delivery.

Marchex, Inc. will hold its 2024 Annual Meeting of Stockholders on October 30, 2024, to elect directors and ratify the appointment of its independent registered public accounting firm.

Marchex, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) related to its upcoming shareholder meeting.

Russell C. Horowitz, Marchex founder and Chairman, transitions to a Schedule 13D filing, reporting beneficial ownership of 18.5% of the company's shares following a recent acquisition.